Lichen International Limited
LICN
$4.41
$0.11912.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 29.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 29.21% | |||
| Cost of Revenue | 0.00% | 21.61% | |||
| Gross Profit | 0.00% | 34.15% | |||
| SG&A Expenses | 0.00% | 126.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 80.76% | |||
| Operating Income | 0.00% | -467.39% | |||
| Income Before Tax | 0.00% | -436.11% | |||
| Income Tax Expenses | 0.00% | -5.20% | |||
| Earnings from Continuing Operations | 0.00% | -997.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -- | |||
| Net Income | 0.00% | -1,000.39% | |||
| EBIT | 0.00% | -467.39% | |||
| EBITDA | 0.00% | -378.33% | |||
| EPS Basic | 0.00% | -759.07% | |||
| Normalized Basic EPS | 0.00% | -347.28% | |||
| EPS Diluted | 0.00% | -759.07% | |||
| Normalized Diluted EPS | 0.00% | -347.28% | |||
| Average Basic Shares Outstanding | 0.00% | 36.58% | |||
| Average Diluted Shares Outstanding | 0.00% | 36.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||